Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Arexvy
Pharma
GSK's RSV vaccine sales plummet in wake of guidance changes
GSK is adopting a “conservative” assumption that the CDC’s immunization panel will not change its RSV guidelines in 2025, CEO Emma Walmsley said.
Angus Liu
Oct 30, 2024 10:41am
GSK's Arexvy shows promise in younger adults
Oct 24, 2024 10:32am
FDA approves Pfizer's RSV shot Abrysvo for all at-risk adults
Oct 23, 2024 11:11am
GSK rolls out positive 3-year data on RSV vaccine Arexvy
Oct 8, 2024 11:29am
GSK touts co-administration data for RSV, shingles vaccines
Sep 18, 2024 11:22am
GSK cuts 2024 vaccines sales amid CDC's narrowed RSV policy
Jul 31, 2024 10:13am
